146 related articles for article (PubMed ID: 34251413)
1. RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia.
Ntoufa S; Gerousi M; Laidou S; Psomopoulos F; Tsiolas G; Moysiadis T; Papakonstantinou N; Mansouri L; Anagnostopoulos A; Stavrogianni N; Pospisilova S; Plevova K; Makris AM; Rosenquist R; Stamatopoulos K
Blood Adv; 2021 Jul; 5(13):2788-2792. PubMed ID: 34251413
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
Ljungström V; Cortese D; Young E; Pandzic T; Mansouri L; Plevova K; Ntoufa S; Baliakas P; Clifford R; Sutton LA; Blakemore SJ; Stavroyianni N; Agathangelidis A; Rossi D; Höglund M; Kotaskova J; Juliusson G; Belessi C; Chiorazzi N; Panagiotidis P; Langerak AW; Smedby KE; Oscier D; Gaidano G; Schuh A; Davi F; Pott C; Strefford JC; Trentin L; Pospisilova S; Ghia P; Stamatopoulos K; Sjöblom T; Rosenquist R
Blood; 2016 Feb; 127(8):1007-16. PubMed ID: 26675346
[TBL] [Abstract][Full Text] [Related]
3. Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia.
Bretones G; Álvarez MG; Arango JR; Rodríguez D; Nadeu F; Prado MA; Valdés-Mas R; Puente DA; Paulo JA; Delgado J; Villamor N; López-Guillermo A; Finley DJ; Gygi SP; Campo E; Quesada V; López-Otín C
Blood; 2018 Nov; 132(22):2375-2388. PubMed ID: 30181176
[TBL] [Abstract][Full Text] [Related]
4. Not so lost in translation:
Ljungström V; Rosenquist R
Blood; 2018 Nov; 132(22):2317-2319. PubMed ID: 30498067
[No Abstract] [Full Text] [Related]
5. Eukaryotic protein uS19: a component of the decoding site of ribosomes and a player in human diseases.
Graifer D; Karpova G
Biochem J; 2021 Mar; 478(5):997-1008. PubMed ID: 33661277
[TBL] [Abstract][Full Text] [Related]
6. Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia.
Dürig J; Nückel H; Hüttmann A; Kruse E; Hölter T; Halfmeyer K; Führer A; Rudolph R; Kalhori N; Nusch A; Deaglio S; Malavasi F; Möröy T; Klein-Hitpass L; Dührsen U
Blood; 2003 Apr; 101(7):2748-55. PubMed ID: 12456497
[TBL] [Abstract][Full Text] [Related]
7. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
[TBL] [Abstract][Full Text] [Related]
8. NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.
Pozzo F; Bittolo T; Vendramini E; Bomben R; Bulian P; Rossi FM; Zucchetto A; Tissino E; Degan M; D'Arena G; Di Raimondo F; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Gattei V; Dal Bo M
Leukemia; 2017 Nov; 31(11):2407-2415. PubMed ID: 28321119
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia.
Wang L; Brooks AN; Fan J; Wan Y; Gambe R; Li S; Hergert S; Yin S; Freeman SS; Levin JZ; Fan L; Seiler M; Buonamici S; Smith PG; Chau KF; Cibulskis CL; Zhang W; Rassenti LZ; Ghia EM; Kipps TJ; Fernandes S; Bloch DB; Kotliar D; Landau DA; Shukla SA; Aster JC; Reed R; DeLuca DS; Brown JR; Neuberg D; Getz G; Livak KJ; Meyerson MM; Kharchenko PV; Wu CJ
Cancer Cell; 2016 Nov; 30(5):750-763. PubMed ID: 27818134
[TBL] [Abstract][Full Text] [Related]
10. RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia.
Gassner FJ; Zaborsky N; Buchumenski I; Levanon EY; Gatterbauer M; Schubert M; Rauscher S; Hebenstreit D; Nadeu F; Campo E; Egle A; Greil R; Geisberger R
Leukemia; 2021 Apr; 35(4):1053-1063. PubMed ID: 32728184
[TBL] [Abstract][Full Text] [Related]
11. Mutations driving CLL and their evolution in progression and relapse.
Landau DA; Tausch E; Taylor-Weiner AN; Stewart C; Reiter JG; Bahlo J; Kluth S; Bozic I; Lawrence M; Böttcher S; Carter SL; Cibulskis K; Mertens D; Sougnez CL; Rosenberg M; Hess JM; Edelmann J; Kless S; Kneba M; Ritgen M; Fink A; Fischer K; Gabriel S; Lander ES; Nowak MA; Döhner H; Hallek M; Neuberg D; Getz G; Stilgenbauer S; Wu CJ
Nature; 2015 Oct; 526(7574):525-30. PubMed ID: 26466571
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia.
Hortal AM; Oeste CL; Cifuentes C; Alcoceba M; Fernández-Pisonero I; Clavaín L; Tercero R; Mendoza P; Domínguez V; García-Flores M; Pintado B; Abia D; García-Macías C; Navarro-Bailón A; Bustelo XR; González M; Alarcón B
Mol Cancer; 2022 Feb; 21(1):35. PubMed ID: 35120522
[TBL] [Abstract][Full Text] [Related]
13. A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment.
Sbarrato T; Horvilleur E; Pöyry T; Hill K; Chaplin LC; Spriggs RV; Stoneley M; Wilson L; Jayne S; Vulliamy T; Beck D; Dokal I; Dyer MJ; Yeomans AM; Packham G; Bushell M; Wagner SD; Willis AE
Cell Death Dis; 2016 Jun; 7(6):e2249. PubMed ID: 27253413
[TBL] [Abstract][Full Text] [Related]
14. The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome.
Brieghel C; da Cunha-Bang C; Yde CW; Schmidt AY; Kinalis S; Nadeu F; Andersen MA; Jacobsen LO; Andersen MK; Pedersen LB; Delgado J; Baumann T; Mattsson M; Mansouri L; Rosenquist R; Campo E; Nielsen FC; Niemann CU
Clin Cancer Res; 2020 Mar; 26(6):1507-1515. PubMed ID: 31919133
[TBL] [Abstract][Full Text] [Related]
15. Role of ribosomal protein mutations in tumor development (Review).
Goudarzi KM; Lindström MS
Int J Oncol; 2016 Apr; 48(4):1313-24. PubMed ID: 26892688
[TBL] [Abstract][Full Text] [Related]
16. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.
Gordon MS; Kato RM; Lansigan F; Thompson AA; Wall R; Rawlings DJ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5504-9. PubMed ID: 10792036
[TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukemia (CLL)-Then and now.
Rai KR; Jain P
Am J Hematol; 2016 Mar; 91(3):330-40. PubMed ID: 26690614
[TBL] [Abstract][Full Text] [Related]
18. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
Rassenti LZ; Kipps TJ
J Exp Med; 1993 Apr; 177(4):1039-46. PubMed ID: 7681468
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
Huang D; Ovcharenko I
BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1.
Tausch E; Beck P; Schlenk RF; Jebaraj BJ; Dolnik A; Yosifov DY; Hillmen P; Offner F; Janssens A; Babu GK; Grosicki S; Mayer J; Panagiotidis P; McKeown A; Gupta IV; Skorupa A; Pallaud C; Bullinger L; Mertens D; Döhner H; Stilgenbauer S
Haematologica; 2020 Oct; 105(10):2440-2447. PubMed ID: 33054084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]